Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Skinner

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 9, 2026
Clostridioides difficile Infection Deceleration: What Is Next?Dale N Gerding, Andrew M Skinner
Future Microbiology|July 28, 2020
Fidaxomicin for the treatment of <i>Clostridioides difficile</i> in childrenAndrew M Skinner, Tonya Scardina, Larry K Kociolek
The Journal of Antimicrobial Chemotherapy|June 6, 2023
Antimicrobial susceptibility of Clostridioides difficile to omadacycline and comparator antimicrobialsAndrew M Skinner, Laurica A Petrella, Adam Cheknis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 21, 2023
Re: 'The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et alJoffrey van Prehn, Andrew M Skinner, Marcela Krutova, et al.
Open Forum Infectious Diseases|April 26, 2024
Management and Outcomes of Patients at a Specialty Clinic for <i>Clostridioides difficile</i> InfectionAaron Hunt, Larry H Danziger, Stuart Johnson, et al.
The New England Journal of Medicine|February 15, 2023
Oral Vancomycin as Secondary Prophylaxis for Prevention of Recurrent <i>Clostridioides difficile</i> InfectionLeslie L Chang, Jessica Allegretti, Andrew M Skinner, et al.
Infection Control and Hospital Epidemiology|October 10, 2024
Risk of rehospitalization due to <i>Clostridioides difficile</i> infection among hospitalized patients with <i>Clostridioides difficile</i>: a cohort studyEmily N Drwiega, Stuart Johnson, Larry H Danziger, et al.
Plos Neglected Tropical Diseases|February 5, 2025
Enteritis necroticans and Clostridium perfringens type C; Epidemiological and pathological findings over the past 20 yearsStuart Johnson, Andrew M Skinner, Calob Lostutter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Can Clostridium innocuum Masquerade as Clostridioides difficile?Andrew M Skinner, Laurica Petrella, Stacey Spandoni, et al.
Open Forum Infectious Diseases|July 14, 2017
Antimicrobial Stewardship Lessons From Mupirocin Use and Resistance in Methicillin-Resitant <i>Staphylococcus Aureus</i>Lance R Peterson, Noelle I Samia, Andrew M Skinner, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 9, 2026
Clostridioides difficile Infection Deceleration: What Is Next?Dale N Gerding, Andrew M Skinner
Future Microbiology|July 28, 2020
Fidaxomicin for the treatment of <i>Clostridioides difficile</i> in childrenAndrew M Skinner, Tonya Scardina, Larry K Kociolek
The Journal of Antimicrobial Chemotherapy|June 6, 2023
Antimicrobial susceptibility of Clostridioides difficile to omadacycline and comparator antimicrobialsAndrew M Skinner, Laurica A Petrella, Adam Cheknis, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 21, 2023
Re: 'The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes' by Stabholz et alJoffrey van Prehn, Andrew M Skinner, Marcela Krutova, et al.
Open Forum Infectious Diseases|April 26, 2024
Management and Outcomes of Patients at a Specialty Clinic for <i>Clostridioides difficile</i> InfectionAaron Hunt, Larry H Danziger, Stuart Johnson, et al.
The New England Journal of Medicine|February 15, 2023
Oral Vancomycin as Secondary Prophylaxis for Prevention of Recurrent <i>Clostridioides difficile</i> InfectionLeslie L Chang, Jessica Allegretti, Andrew M Skinner, et al.
Infection Control and Hospital Epidemiology|October 10, 2024
Risk of rehospitalization due to <i>Clostridioides difficile</i> infection among hospitalized patients with <i>Clostridioides difficile</i>: a cohort studyEmily N Drwiega, Stuart Johnson, Larry H Danziger, et al.
Plos Neglected Tropical Diseases|February 5, 2025
Enteritis necroticans and Clostridium perfringens type C; Epidemiological and pathological findings over the past 20 yearsStuart Johnson, Andrew M Skinner, Calob Lostutter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Can Clostridium innocuum Masquerade as Clostridioides difficile?Andrew M Skinner, Laurica Petrella, Stacey Spandoni, et al.
Open Forum Infectious Diseases|July 14, 2017
Antimicrobial Stewardship Lessons From Mupirocin Use and Resistance in Methicillin-Resitant <i>Staphylococcus Aureus</i>Lance R Peterson, Noelle I Samia, Andrew M Skinner, et al.
Pageof 4